Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Pharmacotherapy of Gaucher Disease: Current and Future Options.

Bennett LL, Fellner C.

P T. 2018 May;43(5):274-309.

2.

Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage.

Mondal A, Bennett LL.

Biomed Pharmacother. 2016 Dec;84:1906-1914. doi: 10.1016/j.biopha.2016.10.096. Epub 2016 Nov 15.

PMID:
27863838
3.

Multifaceted ability of naturally occurring polyphenols against metastatic cancer.

Zhou Q, Bennett LL, Zhou S.

Clin Exp Pharmacol Physiol. 2016 Apr;43(4):394-409. doi: 10.1111/1440-1681.12546. Review.

PMID:
26773801
4.

Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease.

Bennett LL, Turcotte K.

Drug Des Devel Ther. 2015 Aug 18;9:4639-47. doi: 10.2147/DDDT.S77760. eCollection 2015. Review. Erratum in: Drug Des Devel Ther. 2015;9:5213.

5.

Enzalutamide (Xtandi) for patients with metastatic, resistant prostate cancer.

Bennett LL, Ingason A.

Ann Pharmacother. 2014 Apr;48(4):530-7. doi: 10.1177/1060028013518899. Epub 2014 Jan 23. Review.

PMID:
24458946
6.

Gaucher disease and its treatment options.

Bennett LL, Mohan D.

Ann Pharmacother. 2013 Sep;47(9):1182-93. doi: 10.1177/1060028013500469. Review.

PMID:
24259734
7.

Pharmacy curriculum outcomes assessment for individual student assessment and curricular evaluation.

Scott DM, Bennett LL, Ferrill MJ, Brown DL.

Am J Pharm Educ. 2010 Dec 15;74(10):183.

8.

Breast augmentation: A geographical comparison.

Maher JL, Bennett DC, Bennett LL, Grothaus P, Mahabir RC.

Can J Plast Surg. 2010 Winter;18(4):e44-6.

9.

Sweet's syndrome presenting as acute hand infection.

O'Halloran LE, Bennett LL, Grothaus PC, Lynch DJ.

Plast Reconstr Surg. 2005 Aug;116(2):497-501.

PMID:
16079680
10.

Comparative evaluation of topical antiseptic/antimicrobial treatment on aspects of wound repair in the porcine model.

Nanney LB, Bennett LL.

Ostomy Wound Manage. 2002 Sep;Suppl:14-9. No abstract available.

PMID:
12298220
11.

An in vivo comparison of topical agents on wound repair.

Bennett LL, Rosenblum RS, Perlov C, Davidson JM, Barton RM, Nanney LB.

Plast Reconstr Surg. 2001 Sep 1;108(3):675-87.

PMID:
11698839
12.

Diet selection by steers using microhistological and stable carbon isotope ratio analyses.

Bennett LL, Hammond AC, Williams MJ, Chase CC Jr, Kunkle WE.

J Anim Sci. 1999 Aug;77(8):2252-8.

PMID:
10462006
13.

Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylase.

Secrist JA 3rd, Parker WB, Allan PW, Bennett LL Jr, Waud WR, Truss JW, Fowler AT, Montgomery JA, Ealick SE, Wells AH, Gillespie GY, Gadi VK, Sorscher EJ.

Nucleosides Nucleotides. 1999 Apr-May;18(4-5):745-57.

PMID:
10432677
15.

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells.

Parker WB, Allan PW, Shaddix SC, Rose LM, Speegle HF, Gillespie GY, Bennett LL Jr.

Biochem Pharmacol. 1998 May 15;55(10):1673-81.

PMID:
9634004
16.
17.

In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.

Parker WB, King SA, Allan PW, Bennett LL Jr, Secrist JA 3rd, Montgomery JA, Gilbert KS, Waud WR, Wells AH, Gillespie GY, Sorscher EJ.

Hum Gene Ther. 1997 Sep 20;8(14):1637-44.

PMID:
9322865
18.

Lack of mitochondrial toxicity in CEM cells treated with carbovir.

Parker WB, Shaddix SC, Vince R, Bennett LL Jr.

Antiviral Res. 1997 May;34(3):131-6.

PMID:
9191020
19.

Metabolism and metabolic actions of 4'-thiothymidine in L1210 cells.

Parker WB, Shaddix SC, Rose LM, Tiwari KN, Montogmery JA, Secrist JA 3rd, Bennett LL Jr.

Biochem Pharmacol. 1995 Aug 25;50(5):687-95.

PMID:
7669072
20.

Performance, carcass yield, and carcass quality characteristics of steers finished on rhizoma peanut (Arachis glabrata)-tropical grass pasture or concentrate.

Bennett LL, Hammond AC, Williams MJ, Kunkle WE, Johnson DD, Preston RL, Miller MF.

J Anim Sci. 1995 Jul;73(7):1881-7.

PMID:
7592069
21.

Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines.

Sorscher EJ, Peng S, Bebok Z, Allan PW, Bennett LL Jr, Parker WB.

Gene Ther. 1994 Jul;1(4):233-8.

PMID:
7584086
22.
23.

Phosphonate analogs of carbocyclic nucleotides.

Elliott RD, Rener GA, Riordan JM, Secrist JA 3rd, Bennett LL Jr, Parker WB, Montgomery JA.

J Med Chem. 1994 Mar 18;37(6):739-44.

PMID:
8145223
24.

Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase.

Bennett LL Jr, Parker WB, Allan PW, Rose LM, Shealy YF, Secrist JA 3rd, Montgomery JA, Arnett G, Kirkman RL, Shannon WM.

Mol Pharmacol. 1993 Dec;44(6):1258-66.

PMID:
8264563
25.

Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compounds.

Bennett LL Jr, Allan PW, Noker PE, Rose LM, Niwas S, Montgomery JA, Erion MD.

J Pharmacol Exp Ther. 1993 Aug;266(2):707-14.

PMID:
8355201
26.

Metabolism of carbovir, a potent inhibitor of human immunodeficiency virus type 1, and its effects on cellular metabolism.

Parker WB, Shaddix SC, Bowdon BJ, Rose LM, Vince R, Shannon WM, Bennett LL Jr.

Antimicrob Agents Chemother. 1993 May;37(5):1004-9.

27.

Incorporation of the carbocyclic analog of 2'-deoxyguanosine into the DNA of herpes simplex virus and of HEp-2 cells infected with herpes simplex virus.

Parker WB, Shaddix SC, Allan PW, Arnett G, Rose LM, Shannon WM, Shealy YF, Montgomery JA, Secrist JA 3rd, Bennett LL Jr.

Mol Pharmacol. 1992 Feb;41(2):245-51.

PMID:
1311407
28.

The Long and Evans monograph on the estrous cycle in the rat.

Bennett LL.

Endocrinology. 1991 Dec;129(6):2812-4. No abstract available.

PMID:
1954869
29.

Urinary desmosine excretion as a marker of lung injury in the adult respiratory distress syndrome.

Tenholder MF, Rajagopal KR, Phillips YY, Dillard TA, Bennett LL, Mundie TG, Tellis CJ.

Chest. 1991 Nov;100(5):1385-90.

PMID:
1935298
30.

Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.

Parker WB, Shaddix SC, Chang CH, White EL, Rose LM, Brockman RW, Shortnacy AT, Montgomery JA, Secrist JA 3rd, Bennett LL Jr.

Cancer Res. 1991 May 1;51(9):2386-94.

31.
32.

Sodium-dependent nucleoside transport in mouse leukemia L1210 cells.

Dagnino L, Bennett LL Jr, Paterson AR.

J Biol Chem. 1991 Apr 5;266(10):6308-11.

33.

Phosphorylation of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes viruses.

Bennett LL Jr, Shealy YF, Allan PW, Rose LM, Shannon WM, Arnett G.

Biochem Pharmacol. 1990 Oct 1;40(7):1515-22.

PMID:
2171531
34.

A new isotopic assay for purine nucleoside phosphorylase.

Chang CH, Bennett LL Jr, Brockman RW.

Anal Biochem. 1989 Dec;183(2):279-82.

PMID:
2516416
35.

Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds. Role of adenylate deaminase.

Bennett LL Jr, Brockman RW, Allan PW, Rose LM, Shaddix SC.

Biochem Pharmacol. 1988 Apr 1;37(7):1233-44.

PMID:
3355597
36.

Stimulation of insulin secretion by beta-endorphins (1-27 & 1-31).

Curry DL, Bennett LL, Li CH.

Life Sci. 1987 May 25;40(21):2053-8.

PMID:
3035302
37.

I.L. Chaikoff, biochemical physiologist, and his students.

Bennett LL.

Perspect Biol Med. 1987 Spring;30(3):362-83. No abstract available.

PMID:
3295750
38.

Evidence that the carbocyclic analog of adenosine has different mechanisms of cytotoxicity to cells with adenosine kinase activity and to cells lacking this enzyme.

Bennett LL Jr, Bowdon BJ, Allan PW, Rose LM.

Biochem Pharmacol. 1986 Nov 15;35(22):4106-9. No abstract available.

PMID:
3022752
39.

Synthesis and biochemical properties of 8-amino-6-fluoro-9-beta-D-ribofuranosyl-9H-purine.

Secrist JA 3rd, Bennett LL Jr, Allan PW, Rose LM, Chang CH, Montgomery JA.

J Med Chem. 1986 Oct;29(10):2069-74.

PMID:
3489838
40.

Overnight nasal CPAP improves hypersomnolence in sleep apnea.

Rajagopal KR, Bennett LL, Dillard TA, Tellis CJ, Tenholder MF.

Chest. 1986 Aug;90(2):172-6.

PMID:
3525021
41.

Differences in the metabolism and metabolic effects of the carbocyclic adenosine analogs, neplanocin A and aristeromycin.

Bennett LL Jr, Allan PW, Rose LM, Comber RN, Secrist JA 3rd.

Mol Pharmacol. 1986 Apr;29(4):383-90.

PMID:
3702857
43.

Metabolism and metabolic effects of 2-azahypoxanthine and 2-azaadenosine.

Bennett LL Jr, Smithers D, Rose LM, Adamson DJ, Shaddix SC, Thomas HJ.

Biochem Pharmacol. 1985 Apr 15;34(8):1293-304.

PMID:
2859858
44.

His future foretold--the 1904 address by Herbert Evans.

Bennett LL.

Perspect Biol Med. 1985 Autumn;29(1):153-63. No abstract available.

PMID:
3906554
45.

Multiple calcified chondrohamartomas of the lung: CT appearance.

Bennett LL, Lesar MS, Tellis CJ.

J Comput Assist Tomogr. 1985 Jan-Feb;9(1):180-2. Review.

PMID:
3881488
46.

Mode of action of 2-amino-6-chloro-1-deazapurine.

Bennett LL Jr, Smithers D, Rose LM, Adamson DJ, Brockman RW.

Biochem Pharmacol. 1984 Jan 15;33(2):261-71.

PMID:
6142712
47.

Magnesium requirement for somatostatin inhibition of insulin secretion.

Curry DL, Bennett LL.

Acta Endocrinol (Copenh). 1984 Jan;105(1):83-6.

PMID:
6141690
48.

Phosphorylation of "tricyclic nucleoside" by adenosine kinases from L1210 cells and HEp-2 cells.

Bennett LL Jr, Allan PW, Chang CH.

Biochem Pharmacol. 1983 Sep 1;32(17):2601-2. No abstract available.

PMID:
6311222
49.

Kinetic studies of adenosine kinase from L1210 cells: a model enzyme with a two-site ping-pong mechanism.

Chang CH, Cha S, Brockman RW, Bennett LL Jr.

Biochemistry. 1983 Feb 1;22(3):600-11.

PMID:
6301523
50.

What causes fatty liver after pancreatectomy--an unresolved and forgotten controversy. The 1936-1954 years of controversy.

Bennett LL.

Perspect Biol Med. 1983 Summer;26(4):595-612. No abstract available.

PMID:
6622202

Supplemental Content

Loading ...
Support Center